Same framework, applied to Pharmacology
The framework's value lies in its universality across disparate domains. The brake operator \(\mathcal{B}\), dispersion \(\mathcal{S}\), consensus \(\mathcal{M}\), spectral primitive \(\mathcal{P}\), anti-shadow detector \(\mathfrak{A}\), and scope-reporter \(\mathscr{A}\) — together with Theorems 1–13 — are applied here exactly as on every other domain. Source code: github.com/senuamedia/uniformity. No per-domain calibration. No imported threshold. No bespoke fit.
Cross-domain catalogue — \(\beta\)-strip
This domain has no catalogue instance reported yet. The chart below shows the framework's brake-exponent readings across every other domain — the same operators apply unchanged when data are added here.
Click any point for the full reading: instance, domain, \(\beta\) value, and a link to the source code.
What the framework provides for pharmacology
Pharmacology has a strong domain-specific language for dose–response (Hill equation, IC50, EC50). The framework's planned contribution is a dimensionless cross-drug-class language: brake exponent \(\beta\) per drug, cross-class \(\sigma_{\text{cross}}\) tests whether pharmacodynamic response is universal or class-specific. The framework's medical bump-hunt validation (instance 7, Wisconsin breast cancer) demonstrates the same primitive operates cleanly on biomedical data; pharmacology applies it at a different scale.
Status
Open direction
No strong catalogue instance yet specific to pharmacology dose-response. Medical bump-hunt (instance 7) validates the related primitive on biomarker discovery. domains/pharmacology/.
Open applications
- Cross-class dose-response universality on CCLE / CTRP / GDSC matrices.
- Drug-repurposing bump-hunt on Connectivity-Map-style signatures.
- Combination synergy in framework language: \(\beta(\text{combination})\) vs \(\beta(\text{single})\).
Framework reading
Honest reporting under Law V: this domain has no catalogue instance reported. Medical bump-hunt (instance 7) demonstrates the framework's primitive ranks 6/7 literature-consensus biomarkers in its top 7 — extending to dose-response is a parallel application of the same operators.